Calcitonin gene-related peptide: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
||
Line 20: | Line 20: | ||
{{SI}} | {{SI}} | ||
'''Calcitonin gene related peptide''' (CGRP) is derived, with [[calcitonin]], from the CT/CGRP gene located on [[chromosome 11]]. CGRP is a 37 amino acid peptide and is the most potent endogenous [[vasodilator]] currently known. | '''Calcitonin gene related peptide''' (CGRP) is derived, with [[calcitonin]], from the CT/CGRP gene located on [[chromosome 11]]. CGRP is a 37 amino acid peptide and is the most potent endogenous [[vasodilator]] currently known. | ||
Line 35: | Line 35: | ||
{{Neuropeptides}} | {{Neuropeptides}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} |
Revision as of 23:21, 8 August 2012
calcitonin-related polypeptide, beta | |
---|---|
Identifiers | |
Symbol | CALCB |
Alt. symbols | CALC2 |
Entrez | 797 |
HUGO | 1438 |
OMIM | 114160 |
RefSeq | NM_000728 |
UniProt | P10092 |
Other data | |
Locus | Chr. 11 p14.2-p12 |
Calcitonin gene related peptide (CGRP) is derived, with calcitonin, from the CT/CGRP gene located on chromosome 11. CGRP is a 37 amino acid peptide and is the most potent endogenous vasodilator currently known.
CGRP is primarily produced in nervous tissue, however, its receptors are expressed throughout the body. CGRP is also strongly implicated in the vasodilatory effect of endogenous cannabinoid anandamide is the brain. This effect was found to be antagonised by capsazepine.[1] CGRP is also currently a major target of research in regards to factors effecting the onset of migrane headaches.
External Links
- Calcitonin+Gene-Related+Peptide at the US National Library of Medicine Medical Subject Headings (MeSH)
References